Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Oct 15, 2021; 13(10): 1317-1335
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1317
Published online Oct 15, 2021. doi: 10.4251/wjgo.v13.i10.1317
Ref. | n | Year | Status | Survival time (mo) |
Gall et al[96], 1991 | 113 | 1970-1989 | Curative resection | 42 |
Non-curative resection (metastasis +) | 12.5 | |||
Cubertafond et al[97], 1994 | 724 | 1980-1989 | Curative resection 25% | Overall 3 |
Non-curative resection 75% | ||||
Jarnagin et al[98], 2003 | 97 | 1990-2001 | Curative resection | 31.3 |
Hawkins et al[29], 2004 | 240 | 1995-2002 | Curative resection | 34 |
Non-curative resection | 8 | |||
Nishio et al[99], 2007 | 166 | 1977-2004 | Curative resection | 12 |
Non-curative resection | 6 | |||
Duffy et al[28], 2008 | 206 | 1995-2005 | Overall | 10.3 |
Incidental GBC | 15.7 | |||
Curative surgery | 30.3 | |||
Curative surgery + adjuvant therapy | 23.4 | |||
D’Hondt et al[25], 2013 | 102 | 1998-2008 | Overall | 7.2 |
Incidental GBC | 25.8 | |||
Non-Incidental GBC | 4.4 | |||
Butte et al[100], 2011 | 261 | 1999-2007 | Overall | DSS 16.97 |
Ito et al[55], 2011 | 122 | 1992-2007 | R0 resection | DSS 41 |
Butte et al[101], 2014 | 135 | 1998-2009 | Overall | DFS 25.9 |
Residual disease | 11.2 | |||
Non-residual disease | 93.4 | |||
Ethun et al[18], 2017 | 449 | 2000-2014 | Incidental GBC | 27.6 |
Zhang et al[102], 2018 | 1422 | 2010-2014 | Resection | 13 |
Yu et al[86], 2019 | 81 | 2006-2015 | T3 Anatomical resection | 54 |
T3 Wedge resection | 49 | |||
Ref. | n | Year | Status | Survival rate (%) |
Ogura et al[103], 1991 | 1686 | 1979-1988 | Radical resection | 66.2 (3 yr) 50.7 (5 yr) |
Non-radical resection | 14.1 (3 yr) 6.2 (5 yr) | |||
Cubertafond et al[97], 1994 | 724 | 1980-1989 | Curative resection 25% | Overall 14 (1 yr) 5 (5 yr) |
Non-curative resection 75% | ||||
Carriaga and Henson[104], 1995 | 4412 | 1973-1987 | Overall | 12.3 (5 yr) |
Bartlett et al[105], 1996 | 149 | 1985-1993 | Resection | 51 (5 yr) |
Fong et al[17], 2000 | 410 | 1986-2000 | Resection | 38 (5 yr) |
Non-resection | 4 (5 yr) | |||
Nakeeb et al[106], 2002 | 140 | 1990-2001 | Resection | 31 (5 yr) |
Pawlik et al[107], 2007 | 115 | 1984-2006 | Resection | 12 (5 yr) |
Kayahara and Nagakawa[57], 2007 | 4770 | 1988-1997 | Overall | 39 (5 yr) |
Shih et al[108], 2007 | 107 | 1995-2004 | Overall | 15 (5 yr) |
Incidental GBC | 33 (5 yr) | |||
D’Angelica et al[59], 2009 | 109 | 1988-2002 | Overall | 42 (5 yr) |
Fuks et al[15], 2011 | 218 | 1998-2008 | Incidental GBC | 41 (5 yr) |
Hari et al[109], 2013 | 1115 | 1988-2008 | Cholecystectomy | 50 (5 yr) |
Cholecystectomy + LN dissection | 70 (5 yr) | |||
Radical cholecystectomy | 79 (5 yr) | |||
Barreto et al[110], 2014 | 163 | 2003-2010 | Overall | DFS 79.6 (2 yr) |
Shindoh et al[42], 2015 | 252 | 1981-2011 | T2 | 42.6 (5 yr) |
- Citation: Okumura K, Gogna S, Gachabayov M, Felsenreich DM, McGuirk M, Rojas A, Quintero L, Seshadri R, Gu K, Dong XD. Gallbladder cancer: Historical treatment and new management options. World J Gastrointest Oncol 2021; 13(10): 1317-1335
- URL: https://www.wjgnet.com/1948-5204/full/v13/i10/1317.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i10.1317